Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Presage® ST2 Assay Enters Routine Use for Heart Failure Patient Care

January 3, 2012 By AxoGen, Inc.

SAN DIEGO–(BUSINESS
WIRE
)–Critical Diagnostics, a U.S.-based biomarker company focused on
cardiovascular diseases, announced today that a major European medical center,
Hospital Germans Trias i Pujol in Barcelona Spain, is now using the companys
Presage® ST2 Assay for routine care and management of their heart failure
patients.

“This commitment by Dr. Bayes-Genis is a powerful
endorsement regarding the clinical value of the Presage ST2 Assay,” says James
Snider, President of Critical Diagnostics.

The Presage® ST2 Assay quantitatively measures the level of
ST2 in blood. ST2 has been shown to be a significant predictor of mortality as
well as all-cause hospitalization, mortality due to cardiovascular disease, and
hospitalization due to cardiovascular disease. ST2 is prognostic for clinically
important outcomes in addition to all-cause mortality.

“Different groups worldwide are working together to
study the role of ST2 in humans and our hospital is the first to apply it in
day-to-day operation using the marker in the context of routine care for our
patients,” notes Dr. Antoni Bayes-Genis, head of Cardiology Service at Hospital
Germans Trias i Pujol, and renowned expert in cardiac biomarkers. “Our data
indicates that it refines the prognosis and allows us to separate patients who
will evolve poorly with those who are likely to have a good outcome.

“It is a clear example of translational medicine and
allows us to be pioneers in this field,” adds Bayes-Genis. “We now have a
second generation of heart failure markers. The first generation were the
natriuretic peptides. But we are seeing that ST2 is a marker as powerful or
more than natriuretic peptides for predicting death. If we know which patients
have higher levels of ST2, we must be able to handle them differently and
obtain lower levels of this protein. Therefore, we will establish a protocol
for patients who are at high risk based on this analysis.”

“The Presage ST2 Assay helps clinicians assess patient
prognosis in order to better personalize their care,” states James Snider. “By
selecting the most appropriate treatments and interventions for each patient, a
physician can maximize the clinical benefit from increasingly limited
healthcare resources.”

About Critical Diagnostics and ST2

Critical Diagnostics (www.criticaldiagnostics.com) develops novel diagnostics to
help physicians optimize patient care in cardiovascular diseases, while
containing healthcare costs. The Presage® ST2 Assay has been CE Marked and
cleared by the US FDA. Critical Diagnostics has exclusive worldwide rights to
ST2 for the diagnosis and prognosis of cardiovascular disease.

Posted by Sean Fenske, Editor-in-Chief, MDT

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech